07.24.26 -- BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin

To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

Advanced AAV analytics use high‑resolution multiplex platforms to assess genome integrity and capsid traits, improving accuracy, speeding development, and supporting regulatory quality control.

Early risk identification is critical to predictable technology transfer. Learn how data-driven modeling, multivariate analysis, and proactive collaboration help keep manufacturing timelines on track.

Join this roundtable of biopharmaceutical professionals as they share their insights to help you navigate important quality and planning decisions for the progression of your biologic.

Learn how to implement PAT effectively with a roadmap that covers techniques, validation, data integrity, and lifecycle strategies to help teams improve quality, control, and productivity.